Interestingly, some of them, such as c.-823C > G (rs11075646), located in the 5’-UTR region of CES2 mRNA that enhances its transcription, are related to an increased response to capecitabine and a slow tumor progression in CRC patients [85]. The gene discussed is CES2; the disease is colorectal carcinoma.